Macrophage activation and nitric oxide production by water soluble components of Hericium erinaceum

International Immunopharmacology

Volumn 6, Issue 8, 2006, Pages 1363-1369

  Son, Chang Gue ^a   Shin, Jang Woo ^a   Cho, Jung Hyo ^a   Cho, Chong Kwan ^a   Yun, Cheol Heui ^b   Chung, Wantae ^c   Han, Seung Hyun ^b,d  

^a Daejeon University   (South Korea)

^b International Vaccine Institute   (South Korea)

^c National Institute of Animal Science   (South Korea)

^d School of Dentistry   (South Korea)

Author keywords

Hericium erinaceum; NF B; Nitric oxide

Indexed keywords

HERICIUM ERINACEUM EXTRACT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE EXPRESSION; HERICIUM ERINACEUM; IMMUNOREGULATION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; WESTERN BLOTTING;

AGARICALES; ANIMALS; BIOLOGICAL PRODUCTS; CELL LINE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SOLUBILITY; WATER;

EID: 33745137481     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.03.005     Document Type: Article

References (36)

1. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15 (1997) 23-350
2. Schoedon G., Schneemann M., Walter R., Blau N., Hofer S., Schaffner A., et al. Nitric oxide and infection: another view. Clin Infect Dis 21 Suppl 2 (1995) S152-S157
3. Gomez-Flores R., and Weber R.J. Immunomodulation of macrophage functions by opioids. Adv Exp Med Biol 437 (1998) 13-19
4. Forman H.J., and Torres M. Redox signaling in macrophages. Mol Aspects Med 22 (2001) 189-216
5. Kim S., and Ponka P. Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis. Blood Cells Mol Diseases 29 (2002) 400-410
6. Albina J.E., and Reichner J.S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17 (1998) 39-53
7. Farzaneh-Far R., and Moore K. Nitric oxide and the liver. Liver 21 (2001) 161-174
8. Kleinert H., Schwarz P.M., and Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384 (2003) 1343-1364
9. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 (2001) 593-615
10. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31 (1999) 577-596
11. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
12. Schmitz M.L., Mattioli I., Buss H., and Kracht M. NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5 (2004) 1348-1358
13. Lee E.W., Shizuki K., Hosokawa S., Suzuki M., Suganuma H., Inakuma T., et al. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem 64 (2000) 2402-2405
14. Kenmoku H., Shimai T., Toyomasu T., Kato N., Sassa T., and Erinacine Q. A new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the basidiomycete. Biosci Biotechnol Biochem 66 (2002) 571-575
15. Chang R. Functional properties of edible mushrooms. Nutr Rev 54 (1996) S91-S93
16. Choi W.S., Kim C.J., Park B.S., Lee S.E., Takeoka G.R., Kim D.G., et al. Inhibitory effect on proliferation of vascular smooth muscle cells and protective effect on CCl(4)-induced hepatic damage of HEAI extract. J Ethnopharmacol 100 (2005) 176-179
17. Jia L.M., Liu L., Dong Q., and Fang J.N. Structural investigation of a novel rhamnoglucogalactan isolated from the fruiting bodies of the fungus Hericium erinaceus. Carbohydr Res 339 (2004) 2667-2671
18. Mizuno T., Wasa T., Ito H., Suzuki C., and Ukai N. Antitumor-active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called yamabushitake or houtou. Biosci Biotechnol Biochem 56 (1992) 347-348
19. Nakatsugawa M., Takahashi H., Takezawa C., Nakajima K., Harada K., Sugawara Y., et al. Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins. Intern Med 42 (2003) 1219-1222
20. Kawagishi H., Mori H., Uno A., Kimura A., and Chiba S. A sialic acid-binding lectin from the mushroom Hericium erinaceum. FEBS Lett 340 (1994) 56-58
21. Stadler M., Mayer A., Anke H., and Sterner O. Fatty acids and other compounds with nematicidal activity from cultures of Basidiomycetes. Planta Med 60 (1994) 128-132
22. Cho K.J., Han S.H., Kim B.Y., Hwang S.G., Park K.K., Yang K.H., et al. Chlorophyllin suppression of lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells. Toxicol Appl Pharmacol 166 (2000) 120-127
23. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R., et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
24. Han S.H., Jeon Y.J., Yea S.S., and Yang K.H. Suppression of the interleukin-2 gene expression by aflatoxin B1 is mediated through the down-regulation of the NF-AT and AP-1 transcription factors. Toxicol Lett 108 (1999) 1-10
25. Jeon Y.J., Han S.H., Lee Y.W., Lee M., Yang K.H., Kim H.M., et al. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48 (2000) 173-183
26. Han S.H., Yea S.S., Jeon Y.J., Yang K.H., and Kaminski N.E. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells. J Pharmacol Exp Ther 287 (1998) 1105-1112
27. Gorman C.M., Moffat L.F., and Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2 (1982) 1044-1051
28. Baeuerle P.A., and Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242 (1988) 540-546
29. Hibbs Jr. J.B., Taintor R.R., and Vavrin Z. Macrophage cytotoxicity: role for l-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235 (1987) 473-476
30. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., MacMicking J.D., et al. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261 (1993) 1445-1448
31. Lowenstein C.J., Hill S.L., Lafond-Walker A., Wu J., Allen G., Landavere M., et al. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97 (1996) 1837-1843
32. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
33. Connelly L., Palacios-Callender M., Ameixa C., Moncada S., and Hobbs A.J. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166 (2001) 3873-3881
34. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
35. Dixit V., and Mak T.W. NF-kappaB signaling. Many roads lead to Madrid. Cell 111 (2002) 615-619
36. Tokunaka K., Ohno N., Adachi Y., Tanaka S., Tamura H., Yadomae T., et al. Immunopharmacological and immunotoxicological activities of a water-soluble (1->3)-beta-d-glucan, CSBG from Candida spp. Int J Immunopharmacol 22 (2000) 383-394